Financefair

In year one, Astatine lost €1 million. Four years later, they signed €96M in orders. The gap between those two numbers is where most businesses get stuck. See how they did it. Explore the full story → https://lnkd.in/dpFw7qAi This is Astatine Ltd's Real Growth Story by Financefair. #Financefair #RealGrowthStories #GrowthFunding #EnergyInfrastructure #ScalingBusiness

Getting the funding is one thing. Being ready to use it well is another. That readiness, the operational and leadership work before the raise, is usually what decides whether a scale-up holds together or comes apart. At Get Funding Ready & Scale Smart on 11 June, our Board Advisor Niall Norton digs into exactly that, alongside Martina Fitzgerald of Scale Ireland and Gerry Walsh of Dynamic Space. A Chartered Accountant with 30+ years in software and telecoms, Niall has gone from CEO of Openet to a $1bn division at Amdocs, with several exits and IPOs along the way. One morning in Dublin. The grants and supports you may already qualify for. How investors think before you ask. A room of founders at the same stage. Places are limited. 👉 Register here: https://lnkd.in/dVwsKfza #ScalingBusiness #FundingReady #DublinEvents #AgileExecutives

Astatine started in 2020 with €250,000 in revenue. In 2024 they signed orders for €96 million. That kind of growth takes the right team, the right timing and the right funding partner.

Growth is real but cash is not keeping up. Solvotrin Therapeutics found a funding solution that gave them the speed and flexibility to scale into new markets without giving up equity.

Hundreds of businesses were being held back. Not for lack of ideas or ambition. But because they could not access the right funding to grow. That is why we founded Financefair.

Growth is real but cash is not keeping up. Otonomee found a better way to scale without giving up equity or control. Non-dilutive funding for scaling Irish businesses.